Inovio Pharmaceuticals Inc (INO)
FDA Accepts for Review INOVIOs BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
FDA Accepts for Review INOVIOs BLA for INO-3107 for the Treatment of Adults with Recurrent Respiratory Papillomatosis (RRP)
📈 **POSITIVE** • Medium confidence analysis (74%) • Strong positive business development • Significant competitive advantage **Sentiment:** Positive (95%) **Content type:** Business